Reilly Me
University of Cambridge
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Reilly Me.
Nutrition | 1999
Victor R. Preedy; Reilly Me; Vinood B. Patel; Peter J. Richardson; Timothy J. Peters
Ethanol is one of the few nutrients that is profoundly toxic. Alcohol causes both whole-body and tissue-specific changes in protein metabolism. Chronic ethanol missuse increases nitrogen excretion with concomitant loss of lean tissue mass. Even acute doses of alcohol elicit increased nitrogen excretion. The loss of skeletal muscle protein (i.e., chronic alcoholic myopathy) is one of several adverse reactions to alcohol and occurs in up to two-thirds of all ethanol misusers. There are a variety of other diseases and tissue abnormalities that are entirely due to ethanol-induced changes in the amounts of individual proteins or groups of tissue proteins; for example, increased hepatic collagen in cirrhosis, reduction in myosin in cardiomyopathy, and loss of skeletal collagen in osteoporosis. Ethanol induces changes in protein metabolism in probably all organ or tissue systems. Clinical studies in alcoholic patients without overt liver disease show reduced rates of skeletal muscle protein synthesis though whole-body protein turnover does not appear to be significantly affected. Protein turnover studies in alcohol misusers are, however, subject to artifactual misinterpretations due to non-abstinence, dual substance misuse (e.g., cocaine or tobacco), specific nutritional deficiencies, or the presence of overt organ dysfunction. As a consequence, the most reliable data examining the effects of alcohol on protein metabolism is derived from animal studies, where nutritional elements of the dosing regimen can be strictly controlled. These studies indicate that, both chronically and acutely, alcohol causes reductions in skeletal muscle protein synthesis, as well as of skin, bone, and the small intestine. Chronically, animal studies also show increased urinary nitrogen excretion and loss of skeletal muscle protein. With respect to skeletal muscle, the reductions in protein synthesis do not appear to be due to the generation of reactive oxygen species, are not prevented with nitric oxide synthase inhibitors, and may be indirectly mediated by the reactive metabolite acetaldehyde. Changes in skeletal muscle protein metabolism have profound implications for whole body physiology, while protein turnover changes in organs such as the heart (exemplified by complex alterations in protein profiles) have important implications for cardiovascular function and morbidity.
Biochemical Pharmacology | 2000
Reilly Me; David Mantle; Jonathan R. Salisbury; Timothy J. Peters; Victor R. Preedy
Experiments were performed to address some outstanding issues and investigate possible mechanisms relating to the acute comparative effects of ethanol on liver and skeletal muscle protein metabolism. Ethanol (EtOH)-treated rats were injected (i.p.) with a bolus of EtOH (75 mmol/kg body weight) and sacrificed at 20 min, 1-, 2.5-, 6-, and 24-hr time points. Control rats were injected with saline (Con-Sal; 0.15 mmol/L NaCl). All 24-hr ethanol-treated animals were compared with saline-injected rats subjected to controlled feeding (i.e. pair-fed controls for 24 hr EtOH). At 24 hr, there was no measurable alcohol in the plasma, whereas high levels were seen from 20 min to 6 hr (up to 448 mg/dL). Plasma levels of albumin were reduced at initial time points, and activities of aspartate aminotransferase increased, but there was no histological evidence of overt tissue damage either in muscle or liver. Hepatic protein and RNA contents and indices of tissue (C(s) and k(s)) and whole-body (V(s)) protein synthesis were significantly increased in ethanol-dosed rats relative to saline-injected pair-fed controls at 24 hr. In the liver, four of the seven cytoplasmic proteases investigated (alanyl-, arginyl-, and pyroglutamyl-aminopeptidases and proline-endopeptidase) showed significant increases in activity at 24 hr relative to pair-fed controls; four of the six lysosomal proteases showed significant decreases in activity (dipeptidyl-aminopeptidase II and cathepsins B, L, and H). In skeletal muscle, k(s) fell progressively between 1 and 24 hr (-25 to -69%; P < 0.001), but no significant changes in skeletal muscle protease activities were seen at 24 hr. At 24 hr after ethanol dosage in vivo, there were no significant increases in protein carbonyl content in liver or skeletal muscle compared to pair-fed controls (muscle levels actually decreased slightly). However, using either rat or human tissue, both liver and muscle carbonyl increased in vitro in response to superoxide and hydroxyl radicals: muscle was more susceptible to carbonyl formation than liver and both tissues were more sensitive to hydroxyl compared to superoxide radicals. These results show divergent effects of acute ethanol treatment on liver and skeletal muscle protein metabolism, which may not be linked to in vivo free radical-mediated protein damage (as indicated by carbonyl formation), at least in the short term.
International Journal of Cardiology | 1995
Victor R. Preedy; Howard Why; Alistair G. Paice; Reilly Me; Heather Ansell; Vinood B. Patel; Peter J. Richardson
Changes in cardiac protein composition occur in a variety of patho-physiological situations and are usually accompanied by modifications in protein synthesis. Although adjustments in protein synthesis during starvation may be adaptive, the alterations in protein synthesis seen in response to ethanol ingestion may be pathological and an important step in the genesis of alcoholic heart muscle disease. The alterations in heart muscle in hypertension are initially adaptive but in the long term they are deleterious, and involve both transcription and translation. While adequate methods exist for quantifying the amount of mRNA for contractile and non-contractile proteins, such studies of gene-expression provide no dynamic information on the rate at which tissue proteins are lost or accrued. This can only be determined by measuring the rate of protein turnover, i.e. either protein synthesis or protein breakdown. Techniques for directly determining the rates of protein breakdown are limited or involve surgical procedures. Methods for measuring the rate of protein synthesis are described, and are illustrated by their application to the investigation of starvation and ethanol toxicity. In particular, attention is focused on the fact that reliable rates of protein synthesis are obtained only if the specific radioactivity of the precursor at the site of protein synthesis (aminoacyl-tRNA) is assessed.
Archive | 1998
Victor R. Preedy; Reilly Me; D. Mantle; Timothy J. Peters
Between one-third and two-thirds of all alcohol abusers have impairments in either muscle function, histology and/or muscle biochemistry, i.e. alcohol-induced muscle disease (AIMD). The chronic form of these lesions (chronic alcoholic myopathy, CAM) are generally characterised by selective atrophy of type II fibres. Affected subjects with CAM loose up to one third of the entire musculature. Clinical studies reveal a lack of correlation with either liver dysfunction, presence of neuropathy or general malnutrition. The activities of plasma carnosinase, an enzyme that cleaves the putative imidazole dipeptide anti-oxidant carnosine, is reduced in myopathic alcoholics, although the pathogenic basis of this is unknown. Plasma selenium and α–tocopherol are also reduced in patients with CAM. Overall, these data implicate free radical-mediated reactions in the pathogenesis of the myopathy, though detailed biochemical analysis in the clinical setting is lacking.
Frontiers in Bioscience | 1999
Victor R. Preedy; Vinood B. Patel; Reilly Me; Peter J. Richardson; Gavin Falkous; David Mantle
Alcoholism: Clinical and Experimental Research | 1997
Reilly Me; David Mantle; Peter J. Richardson; John Salisbury; Jenny Jones; Timothy J. Peters; Victor R. Preedy
Alcoholism: Clinical and Experimental Research | 2000
Junko Adachi; Migiwa Asano; Yasuhiro Ueno; Reilly Me; David Mantle; Timothy J. Peters; Victor R. Preedy
Alcoholism: Clinical and Experimental Research | 1998
Reilly Me; Erylmaz Ei; Amir A; Timothy J. Peters; Victor R. Preedy
Alcoholism: Clinical and Experimental Research | 2000
Robin Koo‐Ng; Gavin Falkous; Reilly Me; Timothy J. Peters; David Mantle; Victor R. Preedy
Archive | 2001
Kari J Buck; Reilly Me; Christoph Fehr